Frontiers in Bioengineering and Biotechnology 期刊简介

Frontiers in Bioengineering and Biotechnology
英文简介:

The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.

In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.

中文简介:(来自Google、百度翻译)

将医学上的新发现转化为临床常规从来都不是一件容易的事。在上个世纪下半叶,由于化学,生物化学和药理学的进步,我们看到了大量药物和装置的开发和应用,这些药物和装置旨在治疗症状,阻断不想要的途径,在传染病的情况下,与负责任的微生物作斗争。然而,今天,我们面临着对病理和疾病的治疗方法的巨大变化。事实上,当前和未来十年的挑战是完全恢复患病生物体的生理状态,并在组织和器官受到严重影响以至于治疗不能局限于症状的抑制或损伤的修复时完全再生。这要归功于基础细胞和分子生物学的重大发展,包括干细胞科学、生长因子递送、基因隔离和转染、生物工程和纳米技术的进步,包括新生物材料的开发、生物制造技术和生物反应器的使用,以及细胞,组织和器官的诊断工具和成像的重大改进。
在当今世界,加强了多学科专家之间的交流,并促进了联合项目以及科学家,工程师,行业人士之间的紧密合作,监管机构和医生是成功开发和临床应用新的生物疗法或涉及生物材料,细胞和/或生物活性分子的集体使用的创新设备的绝对要求。“生物工程和生物技术前沿” 希望通过弥合基础科学发现与其临床应用之间经常存在的差距,成为参与该过程的所有人的论坛。

期刊ISSN
2296-4185
影响指数
5.831
最新CiteScore值
2.80 查看CiteScore评价数据
最新自引率
8.90%
期刊官方网址

hot

https://www.peipusci.com/?type=9
期刊加急投稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015
偏重的研究方向(学科)
Chemical Engineering-Bioengineering
出版周期
出版年份
0
出版国家/地区
Switzerland
是否OA
Yes
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
Frontiers in Bioengineering and Biotechnology 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
工程技术
MULTIDISCIPLINARY SCIENCES(综合性期刊)3区
最新的影响因子
5.831
最新公布的期刊年发文量
年度总发文量 研究类文章占比
1437 76.48%
总被引频次 0
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

Frontiers in Bioengineering and Biotechnology 期刊CiteScore评价数据
最新CiteScore值
2.80
年文章数 1437
SJR
1.081
SNIP
1.339
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Histology #34/60
2 Medicine Biotechnology #158/282
3 Medicine Biomedical Engineering #131/229
4 Medicine Bioengineering #97/148
CiteScore趋势图
CiteScore趋势图
Frontiers in Bioengineering and Biotechnology 投稿经验(由下方点评分析获得,8人参与,15123人阅读)
投稿录用比例: 暂无
审稿速度: 12 Weeks
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司